FDA approves Qelbree, a Non-stimulant Treatment for ADHD
The FDA has approved Qelbree (SPN-812), for children aged 6 to 17 years with attention deficit hyperactivity disorder (ADHD)....
The FDA has approved Qelbree (SPN-812), for children aged 6 to 17 years with attention deficit hyperactivity disorder (ADHD)....
Parkinson’s disease, the most common neurodegenerative movement disorder has growing prevalence with the age. Due to increasing life expectancy...
Most non-surgical options for managing mild sleep apnea simply keep the airway open while the individual sleeps. A new...
Suicide is not a topic that is welcomed with the utmost ease. Religion regards it as a sin, medicine...
Having healthy habits and routines is the best way to avoid contracting unwanted diseases or conditions. However, being a...
Mental health awareness has never been more important than this time when the whole world is in chaos. The...
Do you have loved ones who start to forget specific details in their lives? Have you been listening to...
It is not new to a human being to feel something from the constructive arrangement of sound we consider...
According to the Global Cancer Observatory (GLOBOCAN), in 2018, cervical cancer was the fourth most common type of cancer...